These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33945028)

  • 1. Structural Characterization of KOR Inactive and Active States for 3D Pharmacology and Drug Discovery.
    Zaidi SA; Katritch V
    Handb Exp Pharmacol; 2022; 271():41-64. PubMed ID: 33945028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kappa Opioid Receptor Ligands and Pharmacology: Diphenethylamines, a Class of Structurally Distinct, Selective Kappa Opioid Ligands.
    Spetea M; Schmidhammer H
    Handb Exp Pharmacol; 2022; 271():163-195. PubMed ID: 33454858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How Does Agonist and Antagonist Binding Lead to Different Conformational Ensemble Equilibria of the κ-Opioid Receptor: Insight from Long-Time Gaussian Accelerated Molecular Dynamics Simulation.
    An X; Bai Q; Bing Z; Zhou S; Shi D; Liu H; Yao X
    ACS Chem Neurosci; 2019 Mar; 10(3):1575-1584. PubMed ID: 30372027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current κ opioid receptor ligands and discovery of a new molecular scaffold as a κ opioid receptor antagonist using pharmacophore-based virtual screening.
    Spetea M; Asim MF; Noha S; Wolber G; Schmidhammer H
    Curr Pharm Des; 2013; 19(42):7362-72. PubMed ID: 23448472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel fluoroalkyl derivatives of selective kappa opioid receptor antagonist JDTic: Design, synthesis, pharmacology and molecular modeling studies.
    Schmitt S; Colloc'h N; Perrio C
    Eur J Med Chem; 2015 Jan; 90():742-50. PubMed ID: 25513968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of kappa opioid receptor mediated, dynorphin-stimulated [35S]GTPγS binding in mouse striatum for the evaluation of selective KOR ligands in an endogenous setting.
    Zhou L; Stahl EL; Lovell KM; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM
    Neuropharmacology; 2015 Dec; 99():131-41. PubMed ID: 26160155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pleiotropic Effects of Kappa Opioid Receptor-Related Ligands in Non-human Primates.
    Ko MC; Husbands SM
    Handb Exp Pharmacol; 2022; 271():435-452. PubMed ID: 33274403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor.
    Zheng Z; Huang XP; Mangano TJ; Zou R; Chen X; Zaidi SA; Roth BL; Stevens RC; Katritch V
    J Med Chem; 2017 Apr; 60(7):3070-3081. PubMed ID: 28339199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotype-selective modes of action of κ-opioid receptor agonists.
    Vardy E; Mosier PD; Frankowski KJ; Wu H; Katritch V; Westkaemper RB; Aubé J; Stevens RC; Roth BL
    J Biol Chem; 2013 Nov; 288(48):34470-83. PubMed ID: 24121503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and structural validation of peptide-drug conjugate ligands of the kappa-opioid receptor.
    Muratspahić E; Deibler K; Han J; Tomašević N; Jadhav KB; Olivé-Marti AL; Hochrainer N; Hellinger R; Koehbach J; Fay JF; Rahman MH; Hegazy L; Craven TW; Varga BR; Bhardwaj G; Appourchaux K; Majumdar S; Muttenthaler M; Hosseinzadeh P; Craik DJ; Spetea M; Che T; Baker D; Gruber CW
    Nat Commun; 2023 Dec; 14(1):8064. PubMed ID: 38052802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse.
    Khan MIH; Sawyer BJ; Akins NS; Le HV
    Eur J Med Chem; 2022 Dec; 243():114785. PubMed ID: 36179400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand and G-protein selectivity in the κ-opioid receptor.
    Han J; Zhang J; Nazarova AL; Bernhard SM; Krumm BE; Zhao L; Lam JH; Rangari VA; Majumdar S; Nichols DE; Katritch V; Yuan P; Fay JF; Che T
    Nature; 2023 May; 617(7960):417-425. PubMed ID: 37138078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decoding the κ Opioid Receptor (KOR): Advancements in Structural Understanding and Implications for Opioid Analgesic Development.
    Li Z; Huang R; Xia M; Chang N; Guo W; Liu J; Dong F; Liu B; Varghese A; Aslam A; Patterson TA; Hong H
    Molecules; 2024 Jun; 29(11):. PubMed ID: 38893511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biased Ligands at the Kappa Opioid Receptor: Fine-Tuning Receptor Pharmacology.
    Brust TF
    Handb Exp Pharmacol; 2022; 271():115-135. PubMed ID: 33140224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses.
    Dunn AD; Reed B; Erazo J; Ben-Ezra A; Kreek MJ
    ACS Chem Neurosci; 2019 Aug; 10(8):3590-3600. PubMed ID: 31313902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Label-free cell phenotypic study of opioid receptors and discovery of novel mu opioid ligands from natural products.
    Hou T; Xu F; Peng X; Zhou H; Zhang X; Qiu M; Wang J; Liu Y; Liang X
    J Ethnopharmacol; 2021 Apr; 270():113872. PubMed ID: 33485984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solving an Old Puzzle: Elucidation and Evaluation of the Binding Mode of Salvinorin A at the Kappa Opioid Receptor.
    Puls K; Wolber G
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique Pharmacological Properties of the Kappa Opioid Receptor Signaling Through G
    Barnett ME; Knapp BI; Bidlack JM
    Mol Pharmacol; 2020 Oct; 98(4):462-474. PubMed ID: 32958572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maturational alterations in constitutive activity of medial prefrontal cortex kappa-opioid receptors in Wistar rats.
    Sirohi S; Walker BM
    J Neurochem; 2015 Nov; 135(4):659-65. PubMed ID: 26257334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of serotonin transporter function by kappa-opioid receptor ligands.
    Sundaramurthy S; Annamalai B; Samuvel DJ; Shippenberg TS; Jayanthi LD; Ramamoorthy S
    Neuropharmacology; 2017 Feb; 113(Pt A):281-292. PubMed ID: 27743931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.